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Objectives.This systematic overview of reviews aimed to summarize evidence and methodological quality from systematic reviews
of complementary and alternative medicine (CAM) for the fibromyalgia syndrome (FMS). Methods. The PubMed/MEDLINE,
Cochrane Library, and Scopus databases were screened from their inception to Sept 2013 to identify systematic reviews and
meta-analyses of CAM interventions for FMS. Methodological quality of reviews was rated using the AMSTAR instrument.
Results. Altogether 25 systematic reviews were found; they investigated the evidence of CAM in general, exercised-based
CAM therapies, manipulative therapies, Mind/Body therapies, acupuncture, hydrotherapy, phytotherapy, and homeopathy.
Methodological quality of reviews ranged from lowest to highest possible quality. Consistently positive results were found
for tai chi, yoga, meditation and mindfulness-based interventions, hypnosis or guided imagery, electromyogram (EMG)
biofeedback, and balneotherapy/hydrotherapy. Inconsistent results concerned qigong, acupuncture, chiropractic interventions,
electroencephalogram (EEG) biofeedback, and nutritional supplements. Inconclusive results were found for homeopathy and
phytotherapy. Major methodological flaws included missing details on data extraction process, included or excluded studies, study
details, and adaption of conclusions based on quality assessment. Conclusions. Despite a growing body of scientific evidence of
CAM therapies for the management of FMS systematic reviews still showmethodological flaws limiting definite conclusions about
their efficacy and safety.
1. Introduction
Thefibromyalgia syndrome (FMS) is a chronic condition that
is characterized by chronic widespread pain, fatigue, sleep
disorders, cognitive disturbances, and physical and psycho-
logical distress [1, 2]. Not only did the diagnostic criteria
for FMS change over time but also they are heterogeneous
according to the classification system used.While a diagnosis
according to the earlier criteria of the American College of
Rheumatology required the presence of a specific number
of tender points, more recent guidelines did not define
tender points but focused on the presence of widespread pain
locations [1, 2]. It was estimated that between 2.9 and 3.8%
of the general population in Europe and the US are affected
[3–5], with the majority of patients in clinical settings being
female [2].
Many patients with fibromyalgia utilize complemen-
tary and alternative therapies in addition to conventional
medicine. The most recent German consumers report indi-
cated that almost every FMS patient had used at least one
CAM therapy for the management of FMS in the past, with
the majority being heat application or thermal baths (67.0%),
CAMmedications such as homeopathy, dietary supplements,
and vitamins (35.2%), some kind of diet (34.6%), tool-
based physical therapies such as acupuncture (28.5%), and
meditative exercises such as yoga or tai chi (18.4%) [6].
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In an internet survey with US American FMS patients CAM
treatments were also highly utilized [7]. Contrary to the
highly frequent use data on efficacy and safety are sparse.
Such data are however necessary to judge its value within
the treatment regimen. Without reliable information such
therapies that might benefit FMS patients might also not be
recognized by decision makers.
In the current German guideline for the treatment of
the fibromyalgia only meditative exercise techniques, that
is, yoga, tai chi, or qigong, among others, received a strong
recommendation followed by acupuncture with an open
recommendation. All other complementary therapies were
not recommended when used as monotherapies.
Systematic reviews are literature reviews focusing on the
synthesis of evidence from clinical research; they are the
basis of evidence-based medicine. Systematic reviews are
considered at the highest level of medical evidence; only data
from systematic reviews will receive 1a-evidence according
to the levels of evidence from the Centre of Evidence-Based
Medicine inOxford [8]. However, no systematic review is like
the other, and this especially concerns the methodological
quality [9].
For FMS numerous reviews on the effects of com-
plementary and alternative therapies have been published,
often with contradictory results. This systematic overview
of reviews aimed to provide an overview of evidence from
systematic reviews of CAM for fibromyalgia and to determine
methodological quality of those reviews.
2. Materials and Methods
2.1. Protocol and Registration. This review was planned and
conducted in accordance with the Preferred Reporting Items
for Systematic Reviews andMeta-Analyses (PRISMA) guide-
lines [10]. The protocol was not registered in any database.
2.2. Eligibility Criteria. To be eligible for this overview of sys-
tematic reviews, reviews were required to meet the following
conditions.
(1) Types of Reviews. Systematic reviewswith orwithoutmeta-
analysis were eligible. All reviews claiming to be systematic
were included, as well as all reviews with a systematic litera-
ture search aiming for a comprehensive overview of evidence.
Reviews explicitly stating to have chosen only selected trials,
for example, by personal preference, were excluded.
(2) Types of Participants. Only reviews for patients with
fibromyalgia were included. Reviews for disease classes that
include fibromyalgia, for example, rheumatic diseases in
general, were not eligible. No restrictions regarding age,
gender, conditions duration, or intensity were applied. There
were also no restrictions regarding the diagnostic criteria or
procedures of trials and reviews, and they were all considered
eligible.
(3) Types of Interventions. Reviews on the effects of com-
plementary and alternative (CAM) therapies were included.
For the definition of CAM therapies the definition of the
US American National Institute of Health (NIH) [11] was
followed; this included natural products, mind and body
practices, and other health practices such as holistic medical
systems. Reviews were included if they focused on a single
therapy or on CAM in general. Reviews focusing on therapy
classes that might include CAM therapies, for example,
nonpharmacological therapies, were not considered eligible.
(4) Types of Outcomes. Reviewswere eligible if they assessed at
least one of the following patient-centered outcomes, namely,
pain, quality of life, sleep quality, fatigue, psychological dis-
tress, well-being, and/or safety. Those outcomes were chosen
because they reflect the main symptoms and complaints in
FMS patients [2].
(5) Accessibility of Data. Reviews were eligible only if they
were published as full papers. Only published work in peer-
reviewed journals was included; abstracts or unpublished
work was excluded. Only reviews in English or German were
eligible.
2.2.1. Literature Search. The following electronic databases
were searched from their inception to September 25, 2013:
PubMed/MEDLINE, Scopus, and the Cochrane Library. The
literature search was constructed around search terms for
“fibromyalgia syndrome,” reviews, and meta-analyses and
adapted for each database. For example, the following search
strategy was used on the PubMed/MEDLINE database:
(Fibromyalgia [MeSHTerms]OR fibromyalgia [Title/
Abstract] OR fibrositis
[Title/Abstract] OR FMS [Title/Abstract])
AND
(Review [Publication type] OR meta-analysis [Pub-
lication type] OR systematic [Subset] OR systematic
review [Title/Abstract] OR review
[Title/Abstract] OR meta-analysis [Title/Abstract]).
The reference lists of identified reviews were also searched
manually for relevant articles.
2.2.2. Review Selection. At first all duplicates were removed
from the references. Two reviewers (RL, HC) then screened
the abstracts of the remaining papers individually and went
on to obtain the full papers for potentially eligible reviews.
The reviews were then checked in detail, with eligible papers
being included in this overview.
2.2.3. Data Collection. Two reviewers (RL, HC) indepen-
dently extracted data on reviews’ characteristics (interven-
tion, comparator, types of included studies, number of studies
and patients, information on meta-analysis, risk of bias
assessments, and safety). Disagreements were checked with
a third reviewer (JL) and resolved by agreement.
2.2.4. Methodological Quality. Methodological quality of
reviews was determined using the assessment of the method-
ological quality of systematic reviews (AMSTAR) [12, 13].
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5489 records identified
through database searching
(i) 2021 PubMed/MEDLINE
(ii) 92 Cochrane
(iii) 3376 Scopus
3839 records excluded
after title/abstract screening
3900 records after
duplicates were removed
61 full-text articles
assessed for eligibility
25 of studies included
in overview [50–74]
1 of additional records
identified through other sources
36 full-text articles excluded;
for details see suppl. references
(i) Protocols only [14–16]
(ii) No relevant outcomes [17, 18]
(iii) No CAM [19–34] 
(iv) Not systematic [35–46] 
(v) No fibromyalgia [47] 
(vi) Only summaries [48, 49]
Figure 1: CONSORT flow chart of review inclusion.
The AMSTAR instrument is an 11-item assessment tool
mainly for intervention reviews with good validity and
reliability [12, 13]. The AMSTAR determines whether most
important contents of systematic reviews have been provided,
such as an a priori design, a comprehensive literature search,
information about study selection and data extraction, a list
of included and excluded studies, characteristics of studies,
a quality assessment of included studies, an appropriate
method of combining findings or forming conclusions, and
conflict of interests statements.
3. Results
3.1. Literature Search. The literature search and cross-ref-
erence search retrieved 5489 records, of which 1590 were
duplicates (Figure 1). After abstract screening, 3839 records
were excluded. Of the remaining 61 articles that were assessed
as full text, 36 were excluded for the following reasons: three
of them were only protocols [14–16], two did not report
relevant outcomes [17, 18], 16 did not fit the reviews definition
of CAM therapies as stated in the inclusion criteria [19–34],
12 reviews were not systematic [35–46], one did not review
trials on fibromyalgia [47], and two publications were only
summaries of the results of reviews and medical guidelines
[48, 49].
3.2. Review Characteristics. Finally 25 reviews could be
included; characteristics are presented in Table 1.
The trials were published in the years 2000 (𝑁 = 1), 2003
(𝑁 = 1), 2007 (𝑁 = 1), 2008 (𝑁 = 1), 2009 (𝑁 = 5), 2010
(𝑁 = 4), 2011 (𝑁 = 2), 2012 (𝑁 = 2), and 2013 (𝑁 = 8).
Reviews investigated the following therapies: comple-
mentary and alternative therapies in general (𝑁 = 4) [50–
53], exercised-based therapies (𝑁 = 4) [54–57], manipulative
therapies (𝑁 = 3) [58–60], Mind/Body therapies (𝑁 = 5)
[61–65], acupuncture (𝑁 = 4) [66–69], balneotherapy (𝑁 =
3) [70–72], phytotherapy (𝑁 = 1) [73], and homeopathy
(𝑁 = 1) [74].
RCTs and quasi-RCTs only were included by 17 reviews
[50, 51, 53, 55, 56, 58, 62–64, 66–69, 73, 74]; the other
reviews also included controlled clinical trials [52, 54, 61, 65],
observational trials [70], or any kind of study/review [57, 59,
60]. Reviews included from 4 to 60 trials with a total patient
sample from 163 to 2897. Of the 25 reviews only 11 conducted
meta-analyses.
All but three reviews [59, 68, 70] assessed the risk of bias
of included trials, nine used the Jadad score [51, 54, 57, 58, 63,
64, 69, 73, 74], three used theCochrane risk of bias assessment
[56, 65, 66], three used the van Tulder scale [67, 71, 72],
four applied self-adapted instruments or partial instruments
[53, 55, 62], one the Oxford rating scale [60], one the Consort
rating scale [52] and one the Scale for rating of quality of
psychological trials in pain [61]. Only two reviews explicitly
reported methods for formulating recommendation [56, 65],
and both used the GRADE approach [75].
Quality assessment revealed maximal differences be-
tween the reviews; while some were of highest quality, others
did only receive 2 of 11 possible points; see Table 2. While
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all reviews conducted a systematic literature search (which
explicitly was an inclusion criterion), some of the reviews
did not state an a priori design (𝑁 = 3) [59, 64, 68], and
in some reviews either data extraction was not described or
data were not extracted independently by two people (𝑁 =
12) [50–54, 57, 59, 60, 64, 68]. Only seven reviews listed
included and excluded studies [55, 56, 61, 62, 65, 71, 72],
and comprehensive study characteristics were provided by 14
reviews only [50, 54–57, 59, 61–63, 65, 67, 71, 73]. Risk of bias
assessment was conducted in all but two reviews [59, 68],
but the scientific quality was not appropriately included in
formulating conclusions in nine of those reviews using a risk
of bias assessment [50, 53, 55, 57, 59, 60, 62, 64, 69]. Of those
reviews conducting meta-analyses [53, 55–57, 61, 62, 65–
68, 71] only one used nonappropriate methods to combine
study findings [57].
Likelihood of publication bias was not assessed in the
majority of reviews, and two reviews with meta-analysis
lacked this information [67, 68]. Conflict of interests was
stated in most reviews with only 3 exceptions [52, 63, 72].
3.3. Results of Reviews. Evidence for or against the respective
interventions is summarized in Table 3.
3.3.1. CAM in General. Altogether four reviews stated that
they investigated the effects of CAM in fibromyalgia [50–
53], and only one of them conducted a meta-analysis [53].
The first thing that became evident was that no uniform
definition of CAM exists; while Holdcraft et al. [52] and
Terhorst et al. [53] followed the definition set by the NIH [11],
Baranowsky et al. [50] excluded dietary, nutritional, herbal,
or hormonal supplements. De Silva et al. [51] on the other
hand defined CAM as oral or topical preparations only. Even
within the NIH definition results of literature search showed
a tremendous increase in studies between 2003 and 2011,
resulting in 60 RCTs in 2011 [53] compared to 22 included in
2003 [52]. Quality of CAMreviewswas rather lowwith ranges
from 4 to 6 according to the AMSTAR rating.
Most of those reviews presented separate results for single
CAM treatments; therefore their results were split up and
presented within the respective intervention categories.
3.3.2. Exercise-Based Interventions. Two reviews, with and
without meta-analyses, investigated the effects of qigong [54,
56]. While the first review [54] concluded that it was too
early to draw conclusions, one year later a second review [56]
with almost twice as many studies found moderate-to-strong
short-term effects on most patient relevant outcomes when
compared to usual care.
Within the more comprehensive reviews results were
more equivocal [50, 53, 55, 57]. For yoga as well as tai chi
reviews statedmainly positive results [53, 55, 57], even though
for tai chi only limited evidence was available [55]. Quality of
reviews within this category was mixed with two reviews of
high and two of moderate quality.
3.3.3. Manipulative Therapies. Two reviews were conducted
for chiropracticmanagement [58, 60] and one was conducted
for massage [59], but nometa-analysis was included in either.
The two reviews for chiropractic care were of moderate
quality, and they found limited evidence [60] or no evidence
[58] for effects of chiropractic intervention. Similar results
were reported by the comprehensive reviews [52, 53].
The review on massage was judged to be low quality, and
its conclusion was that “existing literature provides modest
support for use of massage therapy in treating fibromyalgia.”
Holdcraft et al. [52] come to a similar conclusion, while
Terhorst et al. [53] concluded that there was no evidence for
effects of massage at all.
3.3.4. Mind/Body Interventions. Reviews on Mind-Body in-
terventions investigated the effects of any treatment modal-
ity [63], meditation-based interventions [64], mindfulness-
based stress reduction (MBSR) [65], hypnosis or guided
imagery [61], or biofeedback [62]; only 3 of them conducted
meta-analyses [61, 62, 65]. Two comprehensive reviews
also included Mind/Body interventions [50, 52]. Quality of
reviews was considerable heterogeneous with a range from
very low [64] to very high [61].
Almost all reviews found at least limited evidence for
effects of Mind/Body interventions with the exception of
biofeedback [50] and EEG biofeedback in particular [62].
Limited evidence was also found for relaxation [52] but not
autogenic training [50].
3.3.5. Acupuncture. Four reviews were found for the effects
of acupuncture in FMS [66–69], and three comprehen-
sive reviews included acupuncture [50, 52, 53]. Results for
acupuncture were rather varying with reviews finding strong
evidence for effects on pain [52, 66, 67], two finding no
evidence for effects [53, 68] and two with inconclusive results
[50, 69]. Quality of reviews for acupuncture was mixed, with
two low and two high quality reviews.
3.3.6. Hydrotherapy/Balneotherapy. For balneotherapy and/
or hydrotherapy three reviews were found [70–72]. Together
with the comprehensive reviews [50, 52, 53] only positive
evidence of different degrees was found [50, 52, 53, 70–72].
Quality again was very different between the reviews from
very low to very high quality and only one meta-analysis.
3.3.7. Phytotherapy. For phytotherapy only one review was
available [73] and results indicate a need for further studies
before any judgment about effects can be made. This review
was of moderate quality.
3.3.8. Homeopathy. For homeopathy only one standalone
review was available [74], and authors concluded that effec-
tiveness remained unproven. From the more comprehensive
reviews one was coming to the same conclusion, while three
others found at least some/limited evidence [50–52].
3.3.9. Others. The comprehensive reviews also included
nutritional supplements, some of which had limited evidence
[52], while others were considered ineffective [53].
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Table 3: Overview of conclusions for investigated therapies from included systematic reviews.
Intervention Positive evidence Negative evidence Inconclusive
Mind/Body interventions
Mind/Body interventions in general
(i) Effects on pain [53]
(ii) More effective than usual care
for some outcomes [63]
Meditation-based interventions
(i) Mostly positive results [50]
(ii) Most studies indicate
improvement [64]
Mindfulness-based stress reduction Moderate short-term effects on FMSkey symptoms [65]
Hypnosis/guided imagery Strong short-term effects on pain[61]
Biofeedback
(i) Limited evidence for biofeedback
[52]
(ii) Moderate effects on pain for
EMG biofeedback [62]
(i) No positive results [50]
(ii) No effects of EEG
biofeedback [62]
Relaxation Limited evidence [52]
Autogenic training No effects of autogenictraining [50]
Exercised-based CAM
Qigong
(i) Moderate-to-strong short-term
effects on FMS key symptoms [56]
(ii) Moderate effect on functional
disability [57]
(iii) A positive trend [53]
(i) No positive results [50]
(ii) No evidence of effects [55]
Too early to draw
conclusions [54]
Tai Chi
(i) Strong effect on functional
disability [57]
(ii) Moderate effect on sleep quality
[55]
(iii) One study in favor of tai chi [53]
Yoga
(i) Significant effects on pain,
fatigue, depression, and quality of
life [55]
(ii) Moderate effect on functional
disability [57]
Manipulative therapies
Chiropractic interventions Limited evidence [60]
(i) No positive evidence [58]
(ii) Insufficient evidence for
benefit [52]
Not enough evidence [53]
Massage
(i) Moderate evidence [52]
(ii) Massage is beneficial for patients
with fibromyalgia [59]
Ineffective [53]
Acupuncture
(i) Strong evidence [52]
(ii) Strong evidence for small
short-term effects on pain [67]
(iii) Low-to-moderate evidence for
acupuncture compared to usual care
or standard care [66]
(i) Ineffective [53]
(ii) No evidence for
effectiveness [68]
(i) Mixed quality [50]
(ii) Effectiveness not yet
supported, mixed evidence
[69]
Balneotherapy/hydrotherapy
(i) Positive evidence [50]
(ii) Limited evidence [52]
(iii) Effects on pain [53]
(iv) Moderate evidence for pain [69]
(v) Strong evidence [72]
(vi) Appears efficacious [70]
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Table 3: Continued.
Intervention Positive evidence Negative evidence Inconclusive
Phytotherapy
Unclear whether medicinal
products or related natural
products are effective [73]
Nutritional supplements
Limited evidence for diverse
supplements [52] Ineffective [53]
Homeopathy
(i) Positive results [50]
(ii) Limited evidence [52]
(iii) Some evidence [51]
(i) Not enough evidence [53]
(ii) Effectiveness remains
unproven [74]
3.4. Adverse Events. Adverse events were neither assessed nor
reported in 14 reviews [50, 52, 54, 58, 64, 68–72, 74]. In the
other reviews adverse events weremild tomoderate; however
as was pointed out before, many trials did not sufficiently
report on adverse events.
4. Discussion
Altogether 25 systematic reviews investigated the effects of
complementary and alternative therapies for FMS. Topics
included CAM in general, exercised-based CAM therapies,
manipulative therapies, Mind/Body therapies, acupuncture,
balneotherapy, phytotherapy, and homeopathy. Two-thirds
of the reviews included RCTs and quasi-RCTs; however a
substantial number also included other study types from
case reports to reviews. Only 11 reviews conducted a meta-
analysis. A risk of bias assessment of included trials was
included inmost reviews; standardized recommendations for
or against specific therapies on the other hand were used
by two reviews only. Methodological quality of reviews was
completely diverse ranging from lowest to highest possible
quality.
4.1. Homogeneous Findings. Positive results were found for tai
chi, yoga, Mind/Body interventions in general, meditation-
based interventions, mindfulness-based stress reduction,
hypnosis or guided imagery, and balneotherapy or hydrother-
apy. Negative results were reported on autogenic training,
and inconclusive findings were reported for phytotherapy,
however only one review each was available for autogenic
training and phytotherapy.
4.2. Heterogeneous Findings. Heterogeneous findings, that is,
positive and negative findings, were reported for qigong,
chiropractic interventions, biofeedback, acupuncture, and
nutritional supplements. In the following we will try to
determine the source of heterogeneity.
For qigong three reviews found positive evidence [53,
56, 57], and two found negative evidence [50, 55]. Positive
reviews were associated with later publication date, higher
methodological quality, and three times as many included
trials as negative reviews.Therefore positive results appear to
be more valid than negative results.
For chiropractic interventions there is one review with
limited evidence [60] versus two reviews that do not find
positive evidence [52, 58]. No association between time of
publication, methodological quality, and number of included
trials could be found. However the positive review included
all study types limiting the validity of any conclusion. Alto-
gether for chiropractic interventions there seems to be no
reliable positive evidence.
For biofeedback two reviews conclude positive results
[52, 62] and two do not [50, 62]. One reason might be that
only one of the reviews distinguished between EEG and EMG
biofeedback [62]. So while for EMG biofeedback positive re-
sults have been found, no evidence was present for EEG
biofeedback.
For acupuncture the following was found: the later
reviews were published, the more trials were included, the
more frequent meta-analyses were conducted, and the more
conclusive results became. Secondly, results for quality of
reviews were more diverse, but a trend towards higher
quality reviews coming to a positive conclusion can be found.
Therefore one could assume that acupuncture might be
effective for FMS.
For nutritional supplement one review from 2003 [52]
found positive results while one review from 2011 [53]
found negative evidence. One could assume that nutritional
supplements are not effective in the treatment of FMS.
Results of the overview are mostly in line with a previous
overview [45]; however there were also substantial differ-
ences. While Terry et al. [45] only included 5 reviews, we
could include 25. Results on hydrotherapy are positive in both
overviews; the results for massage however are more diverse,
which might have been a result of the inclusion of massage
into the category of manual therapies. According to Terry
et al. [45] also the use of acupuncture appears promising. In
our review we also found that especially high quality reviews
supported positive effects of acupuncture, and this finding
might however be influenced by other factors such as time
which might be connected to better methodological training
or more eligible trials. For homeopathy on the other hand
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the quality of evidence was not supportive of positive or
promising results yet.
The evidence found in this review is not necessarily in
line with current treatment guidelines; for example, there
is conflicting or lacking evidence for qigong, tai chi, or
yoga; nevertheless they are explicitly recommended in the
German guideline [75] because physical activity and self-care
are considered important therapeutic goals in fibromyalgia
patients. Positive evidence on massage on the other hand
did not lead to a positive recommendation per se; instead
availability, costs, and its negative influence on self-efficacy
and coping behavior led to downgrading of recommendation.
4.3. Limitations. Despite all previous findings and conclu-
sion, there are several limitations that might limit the results
of this overview.
The first limitation concerns the inclusion criteria of the
included reviews. While some reviews explicitly included
only certain CAM therapies, others conducted comprehen-
sive reviews for CAM in general. Since the definition of
CAM is not always consistent, this might lead to a different
direction of each review. Two reviews aiming at the efficacy of
CAM therapies in general might therefore end up in contrary
conclusions merely by different definitions of CAM. Also
reviews that focused on physiotherapeutic interventions or
exercise in general might also have summarized evidence
for single CAM interventions; however since their focus was
not on CAM only, they were not included. Furthermore
reviews and the trials they were based on might have used
different diagnostic criteria or procedures, which also might
have influenced the results.
The methodological quality of reviews is probably one
of the major limitations. Quality ranged from lowest to
highest possible, and quality of reviews was also associated
with the direction of results. Particularly for topics with only
low quality reviews available this might limit the validity
of results. This might be problematic since reviews and
meta-analysis are considered highest evidence standard for
guideline developers.
And another limitation concerns the use of terminology
when summarizing evidence, risk of bias, methodological
quality, or recommendations. Most reviews used different
terms that were not consistent with recommendations; this
might result in misinterpretation of results and conclusions.
4.4. Implication for Further Research. In the future the num-
ber of reviews and meta-analyses will increase; this should
be accompanied by increasedmethodological quality, if those
reviews aim to influence treatment guidelines and decision
makers. The more transparent and methodologically sound
a review is conducted the easier it is for decision makers
to rely on the results when developing treatment guidelines.
The following implications, which are not limited to CAM
reviews, can be made for future reviews.
The basis of a good review is a straight and relevant
research question.Defining patients, interventions, compara-
tors, outcomes, and study types before conducting a review
are most essential. They are also the basis of a comprehensive
literature search. All steps from literature search to conclu-
sions must be made visible; this also includes information
such as the following. Was the search limited in terms of
language or publication status? Who extracted data? Why
were studies excluded? What studies were finally included?
How was the quality of those trials? How were results
combined, for example, using a meta-analysis? How did one
come up with a conclusion or recommendation? There are
several guidelines available on how to report a systematic
review; for example, the PRISMA statement [10] provides a
comprehensive list of items to be reported in reviews and
meta-analyses. There are also validated tools for risk of bias
or quality assessment, for example, Cochrane tools, and for
grading recommendations, for example, GRADE [76]. Since
those tools are validated as a whole, they should not be
altered. For several therapies such as massages blinding of
patients and therapists is impossible; however this per se
constitutes a possible risk of bias in those trials, which cannot
be eliminated by eliminating that item from the risk of bias
assessment list.
In summary, the number of reviews on CAM therapies
for the management of fibromyalgia syndrome is increas-
ing. However many reviews still show certain methodolog-
ical flaws limiting definite conclusions about the efficacy
of CAM therapies. Rather consistent positive results were
found for tai chi, yoga, meditation- and mindfulness-based
interventions, hypnosis or guided imagery, EMG biofeed-
back, and balneotherapy/hydrotherapy. Inconsistent results
concerned qigong, acupuncture, chiropractic interventions,
EEG biofeedback, and nutritional supplements. Inconclusive
results were found for homeopathy and phytotherapy.
5. Conclusion
Despite a growing body of scientific evidence of CAM
therapies for the management of FMS systematic reviews
still show methodological flaws limiting definite conclusions
about the efficacy and safety of those therapies.
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